#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4696	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2278	608.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1806	1806	T	678	T,C	601,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4696	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2278	608.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1540	1540	C	682	C,A	597,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6974	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3945	530.0	0	.	n	.	0	A9G	SNP	9	9	A	520	520	G	640	G,A	549,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6974	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3945	530.0	0	.	n	.	0	T695C	SNP	695	695	T	1206	1206	C	548	C,T,A	469,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6974	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3945	530.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2482	2482	C	607	C	530	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6974	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3945	530.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2556	2556	A	641	A,C	555,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6974	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3945	530.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3108	3108	C	681	C	577	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	688	folP	855	855	99.77	folP.l15.c4.ctg.1	1906	108.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1198	1200	AGC	156;156;156	A;G;C	133;135;132	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1456	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3654	119.4	0	.	p	.	0	T243I	NONSYN	727	729	ACA	1139	1141	ATA	119;119;119	A;T;A	102;100;101	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1456	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3654	119.4	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1160	1162	ATA	110;110;110	A;T,C;A	97;95,1;97	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1456	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3654	119.4	1	SNP	p	S91F	0	.	.	271	273	TCC	683	685	TCC	145;147;147	T;C;C	120;119;120	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1456	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3654	119.4	1	SNP	p	D95G	0	.	.	283	285	GAC	695	697	GAC	139;137;137	G;A;C	116;117;115	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1456	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3654	119.4	1	SNP	p	D95N	0	.	.	283	285	GAC	695	697	GAC	139;137;137	G;A;C	116;117;115	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	27	588	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1648	106.9	1	SNP	p	G45D	0	.	.	133	135	GGC	612	614	GGC	156;156;156	G,C;G,A;C	137,1;139,1;138	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	402	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1282	93.8	0	.	n	.	0	.206T	INS	206	206	T	727	727	T	163	T	143	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1432	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3264	131.4	0	.	p	.	0	V421A	NONSYN	1261	1263	GTC	1760	1762	GCC	153;153;152	G;C;C	132;132;130	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1432	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3264	131.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1802	1804	GCA	166;165;163	G;C;A,C	143;142;141,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1432	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3264	131.4	1	SNP	p	D86N	0	.	.	256	258	GAC	755	757	GAC	175;175;176	G;A;C	147;146;145	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1432	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3264	131.4	1	SNP	p	S87W	0	.	.	259	261	AGT	758	760	AGT	173;173;174	A;G;T	147;147;150	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1432	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3264	131.4	1	SNP	p	S87R	0	.	.	259	261	AGT	758	760	AGT	173;173;174	A;G;T	147;147;150	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1432	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3264	131.4	1	SNP	p	S87I	0	.	.	259	261	AGT	758	760	AGT	173;173;174	A;G;T	147;147;150	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1432	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3264	131.4	1	SNP	p	S88P	0	.	.	262	264	TCC	761	763	TCC	174;175;175	T;C;C	151;152;150	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_W_01411c	parE.WHO_W_01411c	1	1	27	1370	parE	1986	1986	99.95	parE.l6.c17.ctg.1	2993	137.2	1	SNP	p	G410V	0	.	.	1228	1230	GGT	1701	1703	GGT	176;176;177	G;G;T	154;154;153	parE.WHO_W_01411c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	1284	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2775	138.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1456	1458	GCA	176;177;175	G,T;C;A	152,1;152;156	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1284	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2775	138.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1459	1461	ATC	175;175;175	A;T;C	154;153;153	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1284	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2775	138.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1471	1473	GTG	175;175;175	G;T,G;G	152;151,1;149	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1284	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2775	138.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1471	1473	GTG	175;175;175	G;T,G;G	152;151,1;149	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1284	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2775	138.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1975	1977	ACC	173;173;173	A;C;C	147;151;150	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1284	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2775	138.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2029	2031	GCG	180;181;180	G;C;G	156;144;148	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1284	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2775	138.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2029	2031	GCG	180;181;180	G;C;G	156;144;148	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1284	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2775	138.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2152	2154	GGT	190;187;184	G;G,T;T	154;160,1;151	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1284	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2775	138.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2161	2163	GGC	186;186;185	G,C;G;C	158,1;155;155	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1284	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2775	138.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2179	2181	CCG	180;180;182	C,A;C;G,A	149,2;159;156,1	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1492	ponA	2397	2397	99.96	ponA.l6.c17.ctg.1	3624	123.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	2003	2005	CTG	135;136;136	C,T;T,C;G	112,1;116,1;115	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	662	porA	1146	1146	99.65	porA.l6.c17.ctg.1	2104	94.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	547	549	GGC	112;112;115	G;G;C	98;97;99	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	662	porA	1146	1146	99.65	porA.l6.c17.ctg.1	2104	94.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	729	729	C	111	C	97	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	T18M	NONSYN	52	54	ACG	555	557	ATG	200;200;200	A;T;G	163;167;167	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	I45V	NONSYN	133	135	ATT	636	638	GTT	202;202;202	G;T;T	165;167;166	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	N121S	NONSYN	361	363	AAC	864	866	AGC	174;172;174	A;G;C	152;153;151	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	867	869	AAA	172;172;171	A;A;A,C	151;153;149,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	894	896	TAT	168;168;168	T;A,T;T	149;143,1;143	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	N134E	NONSYN	400	402	AAT	903	905	GAG	164;163;163	G,A;A;G,T,A	141,1;146;144,1,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	V135F	NONSYN	403	405	GTG	906	908	TTT	162;161;162	T,G;T;T,G	141,1;143;142,2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	G140K	NONSYN	418	420	GGA	921	923	AAA	154;154;154	A,G;A,G;A	134,1;140,1;135	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	930	932	GAA	155;156;157	G,A;A;A	136,1;136;141	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	954	956	GCA	161;160;162	GC,G;C,T;A,C	141,1;138,1;138,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	K207_M208insK	INS	619	619	A	1122	1122	A	161	A	143	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1140	1142	TCA	158;159;160	T,C;C,T;A	138,1;141,1;142	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	842	porB1b	1038	1038	96.28	porB1b.l15.c4.ctg.1	1973	127.6	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1257	1257	T	185	T	154	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2972	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5107	174.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2071	2073	CAT	172;170;169	C,T;A;T	147,1;146;147	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	466	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1269	109.6	1	SNP	p	V57M	1	.	.	169	171	ATG	631	633	ATG	179;179;176	A;T;G	150;149;147	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
